Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Organo Company

6368.T
JP3201600008

Price

7,270.00
Today +/-
-0.49
Today %
-1.09 %
P

Organo stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Organo stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Organo stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Organo stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Organo's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Organo Stock Price History

DateOrgano Price
10/4/20247,270.00 undefined
10/3/20247,350.00 undefined
10/2/20247,300.00 undefined
10/1/20247,440.00 undefined
9/30/20247,000.00 undefined
9/27/20247,480.00 undefined
9/26/20247,330.00 undefined
9/25/20247,060.00 undefined
9/24/20247,030.00 undefined
9/20/20247,210.00 undefined
9/19/20246,970.00 undefined
9/18/20246,740.00 undefined
9/17/20246,600.00 undefined
9/13/20246,510.00 undefined
9/12/20246,510.00 undefined
9/11/20246,300.00 undefined
9/10/20246,270.00 undefined
9/9/20246,080.00 undefined

Organo Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Organo, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Organo from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Organo’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Organo. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Organo’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Organo’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Organo’s growth potential.

Organo Revenue, EBIT and net profit per share

DateOrgano RevenueOrgano EBITOrgano Net Income
2027e187.19 B undefined0 undefined22.29 B undefined
2026e173.06 B undefined0 undefined20.13 B undefined
2025e162.46 B undefined0 undefined18.23 B undefined
2024150.36 B undefined22.54 B undefined17.31 B undefined
2023132.43 B undefined15.21 B undefined11.73 B undefined
2022112.07 B undefined10.85 B undefined9.21 B undefined
2021100.64 B undefined9.58 B undefined7.07 B undefined
202096.52 B undefined9.91 B undefined7.16 B undefined
201992.27 B undefined6.56 B undefined4.45 B undefined
201879.23 B undefined3.82 B undefined2.78 B undefined
201781.11 B undefined4.11 B undefined2.73 B undefined
201678.72 B undefined3.95 B undefined2.49 B undefined
201568.74 B undefined2.4 B undefined1.09 B undefined
201462.1 B undefined833 M undefined664 M undefined
201366.72 B undefined3.5 B undefined2.56 B undefined
201268.5 B undefined4.85 B undefined2.68 B undefined
201161.1 B undefined3.53 B undefined1.86 B undefined
201053.52 B undefined1.85 B undefined646 M undefined
200973.12 B undefined3.06 B undefined1.62 B undefined
200873.59 B undefined3.85 B undefined2.46 B undefined
200778.47 B undefined7.52 B undefined4.48 B undefined
200675.7 B undefined4.25 B undefined2.01 B undefined
200577.61 B undefined3.03 B undefined1.74 B undefined

Organo Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
19971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e
85.179.6372.4869.3988.779.5566.7569.2177.6175.778.4773.5973.1253.5261.168.566.7262.168.7478.7281.1179.2392.2796.52100.64112.07132.43150.36162.46173.06187.19
--6.44-8.98-4.2627.84-10.32-16.093.6912.14-2.463.66-6.21-0.64-26.8114.1712.12-2.60-6.9310.7014.523.04-2.3316.474.604.2711.3618.1613.548.056.538.16
22.9923.4023.7225.3022.6723.5527.0526.7322.2624.6427.6324.5123.1826.0226.1426.8125.2523.4422.6122.5522.9824.1724.8428.2726.1625.4426.4129.16---
19.5618.6417.1917.5620.1118.7318.0518.517.2818.6521.6818.0416.9513.9215.9718.3716.8514.5515.5417.7518.6419.1522.9227.2826.3328.5134.9843.84000
3.332.071.711.594.953.553.694.113.034.257.523.853.061.853.534.853.50.832.43.954.113.826.569.919.5810.8515.2122.54000
3.912.602.362.305.584.465.535.943.905.619.595.244.193.455.787.085.241.343.495.015.074.827.1110.279.529.6811.4914.99---
1.691.250.60.54-0.241.411.411.921.742.014.482.461.620.651.862.682.560.661.092.492.732.784.457.167.079.2111.7317.3118.2320.1322.29
--26.03-52.19-10.68-144.67-689.120.2836.12-9.5715.71122.58-45.06-34.24-60.05187.4644.48-4.44-74.1063.40129.039.901.7960.1460.87-1.2330.2027.3647.575.3110.4410.69
-------------------------------
-------------------------------
13131212121214141212121212121212121211.5211.5246.0646.0545.8445.7645.8845.945.8645.93000
-------------------------------
Details

Keystats

Revenue and Growth

The Organo Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Organo is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (B)INVENTORIES (B)OTHER CURRENT LIAB. (B)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (B)LONG-T. REC. (B)INTANGIBLE ASSETS (B)GOODWILL (M)OTHER NON-CURRENT ASSETS (B)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (B)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (B)UNREAL. GAINS/LOSSES (B)EQUITY (B)LIABILITIES (B)PROVISIONS (B)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (B)LONG-TERM DEBT PORTION (B)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (B)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                       
9.0711.4213.3215.49.4312.899.816.866.035.826.488.638.4913.2514.1310.278.8110.278.947.2111.348.6511.2813.7712.820.215.5617.64
32.3227.7927.7725.7742.5629.1230.2130.9635.0131.9441.7229.5233.121.2624.3229.1531.3224.0530.8936.7632.7436.3840.1238.2851.0853.0874.6481.06
00000000000000000000000001.71.031.14
11.4110.129.059.8212.3510.887.928.8811.166.598.6588.236.389.49.0410.156.168.049.547.047.738.869.8312.8813.4630.821.83
1.141.41.11.61.892.32.422.222.592.472.651.884.694.534.7111.4310.411.211.4316.919.4917.5315.7814.212.9514.4314.7531.8
53.9450.7351.2552.5966.2355.1950.3648.9254.846.8259.548.0354.5145.4252.5559.8960.6751.6859.2970.4170.6170.2976.0476.0889.7102.86136.77153.47
21.1722.8121.9121.9121.0621.4421.0321.8722.4921.9422.4725.7523.522.5722.7321.5921.3420.820.2920.0520.0819.8519.2719.318.972120.820.63
2.532.492.572.483.122.963.244.725.125.372.991.391.060.890.870.851.211.341.431.471.51.71.621.551.912.062.432.84
0.150.070.050.050.060.050.050.050.010.020.010.010.010.010000000000002.830
0.170.20.160.820.720.60.550.590.580.590.550.550.510.430.370.380.330.370.460.671.011.181.211.111.111.080.950.99
0000000000000000000000000000
3.052.112.141.983.673.373.532.832.411.82.181.982.392.152.072.011.772.662.132.212.223.023.123.413.323.513.924.78
27.0627.6826.8227.2328.6428.4128.430.0530.6129.7128.2129.6727.4626.0426.0424.8224.6425.1724.3224.3924.825.7525.2225.3725.3127.6430.9229.23
80.9978.4178.0779.8294.8783.678.7678.9785.4176.5487.777.781.9771.4678.5984.7185.3176.8583.6194.895.4196.04101.26101.45115.01130.51167.68182.7
                                                       
8.238.238.238.238.238.238.238.238.238.238.238.238.238.238.238.238.238.238.238.238.238.238.238.238.238.238.238.23
7.57.57.57.57.57.57.57.57.57.517.517.517.517.517.517.517.517.517.517.517.517.517.517.517.517.517.517.51
10.5511.3111.4911.9311.2912.2313.1714.6415.9117.4421.4823.1324.0524.1225.5227.5129.429.3329.8831.8734.0236.1739.9746.0851.959.626982.91
0000-0.16-0.07-0.11-0.14-0.15-0.07-0.01-0.01-0.29-0.28-0.29-0.36-0.23-0.69-0.25-0.99-0.79-0.32-0.69-0.7-0.230.781.513.03
000000.03-0.370.390.651.060.580.280.070.140.110.110.190.210.2800.290.310.270.140.30.430.540.77
26.2827.0327.2227.6526.8527.9128.4130.6132.1434.1637.7839.1339.5639.7241.0642.9945.0944.5845.6446.6149.2551.8955.2961.2567.7176.5786.78102.45
22.4220.3919.4620.9432.3320.718.6719.9723.5517.8122.8116.7117.6310.1814.9218.1215.0212.0315.1818.4116.3115.6918.5214.3818.1524.3725.5422.68
1.351.331.231.031.311.311.031.091.061.031.221.10.940.820.890.970.950.840.860.940.991.051.171.341.441.481.591.89
6.955.616.496.327.46.815.295.475.974.187.896.094.724.086.084.665.174.193.875.046.046.116.778.856.647.1612.3513.84
00000000000000008.156.186.1611.2113.1112.8812.266.8413.918.1327.4232.57
9.259.8710.110.429.118.3417.97.9410.769.099.248.629.48.977.937.132.71.52.162.411.21.221.220.820.621.931.831.62
39.9837.237.2838.7150.1537.1642.8834.4641.3432.1141.1632.5332.6924.0429.8330.8831.9924.7428.233837.6436.9639.9332.2440.7543.0768.7472.6
12.4711.9611.2811.2411.2411.850.967.676.375.083.792.56.113.723.476.764.052.554.453.852.61.480.252.131.525.8142.48
00013141501057191418304616101288911539159
21.861.91.816.346.416.275.975.44.974.753.393.593.954.184.054.055.35.616.376.125.926.276.215.375.575.665.42
14.4713.8313.1813.0617.5918.287.2313.6511.7810.058.555.99.77.677.6510.828.117.8610.0710.238.737.46.538.356.9111.439.757.95
54.4451.0250.4551.7667.7455.4450.1148.1153.1242.1649.7138.4342.3931.7137.4741.6940.132.638.348.2346.3744.3646.4640.5947.6554.578.4880.56
80.7278.0677.6779.4294.5983.3478.5378.7385.2676.3287.4977.5681.9571.4378.5484.6985.1977.1883.9494.8495.6296.25101.75101.85115.36131.07165.27183
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Organo provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Organo's financial health and stability.

Assets

Organo's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Organo must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Organo after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Organo's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (B)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (B)NON-CASH ITEM (B)PAID INTEREST (M)PAID TAXES (B)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
1.26-0.222.982.913.572.894.297.534.792.751.563.134.963.91.171.973.8343.936.399.859.712.716.04
1.641.541.321.261.171.061.171.131.311.431.391.211.191.161.0710.950.950.970.921.191.211.331.82
000000000000000000000000
0.31-9.480.68-3.27-1.41-4.38-0.61-7.822.26-4.555.2-1.61-11-5.635.93-5.65-9.81.59-4.28-2.23-2.92-15.6-1.72-36.67
0.185.390.490.180.02-0.14-0.540.15-1.880.250.560.98-0.38-0.28-0.440.180.290.0700.560.430.11-1.20.27
3673703333203311932001861952062341581251381067684777080136110129168
0.850.923.890.491.261.781.211.683.61.40.980.871.721.831.010.540.741.291.291.322.622.653.663.15
3.38-2.775.471.073.35-0.574.310.986.48-0.128.713.71-5.23-0.847.73-2.5-4.736.610.635.648.55-4.5811.1-18.54
-1,188-1,390-1,517-895-2,216-1,368-867-1,106-2,601-3,429-534-932-1,010-1,004-536-489-721-1,347-1,146-618-968-1,254-2,798-1,452
-775-540-1,302-2,230-2,375-1,467-1,298786-1,048-3,790-195-1,184414-1,319-1,347-1,053-913-1,312-1,313-153-1,006-1,261-1,520-1,309
0.410.850.22-1.34-0.16-0.1-0.431.891.55-0.360.34-0.251.42-0.32-0.81-0.56-0.190.04-0.170.47-0.04-0.011.280.14
000000000000000000000000
0.23-1.31-0.16-1.33-3.391.45-3.12-1.14-1.914.45-2.91-1.262.630.99-4.752.474.53-0.48-1.44-1.8-3.926.28-0.5817.24
0000000000000000000-273-8-65-354-4
-0.15-1.66-0.58-1.83-3.870.96-3.62-1.66-2.873.74-3.49-1.731.90.29-5.3324.06-0.99-2.12-2.76-5.014.93-2.5914.71
-10-9-35-13-35-38-54-146-21-9-9-42-7-8-13-1557-51-34-36-29-112-181
-376-347-405-463-462-462-462-462-807-691-576-461-691-691-576-460-460-575-633-656-1,047-1,254-1,541-2,347
2.38-4.873.68-3.02-2.92-1.07-0.580.112.55-0.235.080.75-3.1-1.471.46-1.32-1.734.13-2.692.622.5-0.977.39-4.64
2,192-4,1613,9491771,136-1,9413,444-1303,881-3,5508,1772,777-6,240-1,8487,189-2,993-5,4495,262-5215,0267,583-5,8368,303-19,988
000000000000000000000000

Organo stock margins

The Organo margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Organo. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Organo.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Organo's sales revenue. A higher gross margin percentage indicates that the Organo retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Organo's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Organo's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Organo's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Organo. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Organo's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Organo Margin History

Organo Gross marginOrgano Profit marginOrgano EBIT marginOrgano Profit margin
2027e29.16 %0 %11.91 %
2026e29.16 %0 %11.63 %
2025e29.16 %0 %11.22 %
202429.16 %14.99 %11.51 %
202326.41 %11.49 %8.86 %
202225.44 %9.68 %8.22 %
202126.16 %9.52 %7.03 %
202028.27 %10.27 %7.42 %
201924.84 %7.11 %4.82 %
201824.17 %4.82 %3.51 %
201722.98 %5.07 %3.37 %
201622.55 %5.01 %3.16 %
201522.61 %3.49 %1.58 %
201423.44 %1.34 %1.07 %
201325.25 %5.24 %3.84 %
201226.81 %7.08 %3.92 %
201126.14 %5.78 %3.04 %
201026.02 %3.45 %1.21 %
200923.18 %4.19 %2.21 %
200824.51 %5.24 %3.34 %
200727.63 %9.59 %5.7 %
200624.64 %5.61 %2.66 %
200522.26 %3.9 %2.24 %

Organo Stock Sales Revenue, EBIT, Earnings per Share

The Organo earnings per share therefore indicates how much revenue Organo has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Organo earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Organo's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Organo’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Organo's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Organo Revenue, EBIT and net profit per share

DateOrgano Sales per ShareOrgano EBIT per shareOrgano Earnings per Share
2027e4,074.24 undefined0 undefined485.09 undefined
2026e3,766.85 undefined0 undefined438.23 undefined
2025e3,536.02 undefined0 undefined396.8 undefined
20243,273.95 undefined490.89 undefined376.92 undefined
20232,887.43 undefined331.68 undefined255.76 undefined
20222,441.8 undefined236.4 undefined200.67 undefined
20212,193.5 undefined208.78 undefined154.18 undefined
20202,109.16 undefined216.52 undefined156.51 undefined
20192,012.76 undefined143.05 undefined97.11 undefined
20181,720.51 undefined82.98 undefined60.37 undefined
20171,760.99 undefined89.32 undefined59.29 undefined
20166,835.5 undefined342.73 undefined215.78 undefined
20155,967.52 undefined208.17 undefined94.19 undefined
20145,174.67 undefined69.42 undefined55.33 undefined
20135,559.83 undefined291.5 undefined213.67 undefined
20125,708.5 undefined404.17 undefined223.58 undefined
20115,091.42 undefined294.5 undefined154.75 undefined
20104,459.58 undefined153.83 undefined53.83 undefined
20096,093.17 undefined255.08 undefined134.75 undefined
20086,132.67 undefined321.17 undefined204.92 undefined
20076,538.92 undefined627 undefined373 undefined
20066,308.33 undefined354.08 undefined167.58 undefined
20056,467.75 undefined252.08 undefined144.83 undefined

Organo business model

Organo Corp is an internationally operating company specialized in the production and distribution of products in the health and wellness industry. The company was founded in Vancouver, Canada in 2008 by Bernardo Chua. Organo Corp's business model is based on network marketing to sell its products. This has allowed the company to quickly build a large customer base and become active in over 50 countries. The goal of Organo Corp is to help every customer lead a healthier and happier life. Organo Corp is divided into different divisions to offer customers a wide range of products. One of the main divisions is "Organo Gold," which offers coffee and tea products. These products are based on traditional Asian herbs and fungi such as Reishi, Ganoderma, and Cordyceps. These herbs have many active ingredients that strengthen the immune system, increase energy levels, reduce stress, and promote overall well-being. Another division of Organo Corp is "Organo Essentials," which offers products for a healthy everyday life. This includes supplements such as multivitamin tablets, protein powder, and Omega-3 fatty acids. These supplements are made from high-quality ingredients and aim to improve overall well-being. Organo Corp also has a "Personal Care" division, which offers products for personal hygiene. These include soaps, shampoos, creams, and lotions. These products contain natural ingredients such as tea tree oil, aloe vera, shea butter, and various essential oils that are intended to nourish and protect the skin. The company also has an "Organo Graphics" division, which offers marketing materials to help independent distributors of Organo Corp build their own business. This includes brochures, business cards, and sales tools. Organo Corp has also made a name for itself through various philanthropic activities. The company has established the "OG Care Foundation," which advocates for disadvantaged children and their families worldwide. The foundation supports projects in the areas of education, health, and well-being. In summary, Organo Corp is a company specializing in the sale of products in the health and wellness industry. The company offers a wide range of products based on natural ingredients such as Asian herbs and fungi. Through network marketing, Organo Corp has quickly built a large customer base and is now active in over 50 countries. Additionally, the company is committed to supporting disadvantaged children around the world through the "OG Care Foundation." Organo is one of the most popular companies on Eulerpool.com.

Organo SWOT Analysis

Strengths

Organo Corp possesses several key strengths:

  • Strong brand presence and reputation in the market
  • Diverse product portfolio catering to different customer segments
  • Robust distribution network and partnerships
  • Innovative research and development capabilities
  • Efficient supply chain management

Despite its strengths, Organo Corp has certain weaknesses:

  • Limited international presence
  • High reliance on a few key suppliers
  • Slower adoption of digital technologies
  • Dependency on specific market segments
  • Average customer service compared to competitors

Organo Corp can take advantage of the following opportunities:

  • Expanding into new emerging markets
  • Investing in research and development for new products
  • Acquiring or partnering with complementary businesses
  • Improving online presence and e-commerce capabilities
  • Capitalizing on growing demand for sustainable products

Organo Corp should be cautious of the following threats:

  • Intense competition in the industry
  • Changing consumer preferences and trends
  • Inflation and fluctuating raw material prices
  • Government regulations and compliance requirements
  • Economic downturns and market uncertainties

Weaknesses

Despite its strengths, Organo Corp has certain weaknesses:

  • Limited international presence
  • High reliance on a few key suppliers
  • Slower adoption of digital technologies
  • Dependency on specific market segments
  • Average customer service compared to competitors

Organo Corp can take advantage of the following opportunities:

  • Expanding into new emerging markets
  • Investing in research and development for new products
  • Acquiring or partnering with complementary businesses
  • Improving online presence and e-commerce capabilities
  • Capitalizing on growing demand for sustainable products

Organo Corp should be cautious of the following threats:

  • Intense competition in the industry
  • Changing consumer preferences and trends
  • Inflation and fluctuating raw material prices
  • Government regulations and compliance requirements
  • Economic downturns and market uncertainties

Opportunities

Organo Corp can take advantage of the following opportunities:

  • Expanding into new emerging markets
  • Investing in research and development for new products
  • Acquiring or partnering with complementary businesses
  • Improving online presence and e-commerce capabilities
  • Capitalizing on growing demand for sustainable products

Organo Corp should be cautious of the following threats:

  • Intense competition in the industry
  • Changing consumer preferences and trends
  • Inflation and fluctuating raw material prices
  • Government regulations and compliance requirements
  • Economic downturns and market uncertainties

Threats

Organo Corp should be cautious of the following threats:

  • Intense competition in the industry
  • Changing consumer preferences and trends
  • Inflation and fluctuating raw material prices
  • Government regulations and compliance requirements
  • Economic downturns and market uncertainties

Organo Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Organo historical P/E ratio, EBIT multiple, and P/S ratio

Organo shares outstanding

The number of shares was Organo in 2023 — This indicates how many shares 45.863 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Organo earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Organo's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Organo’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Organo's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Organo stock splits

In Organo's history, there have been no stock splits.

Organo dividend history and estimates

In 2023, Organo paid a dividend amounting to 74 JPY. Dividend means that Organo distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for Organo provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Organo’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Organo's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Organo Dividend History

DateOrgano Dividend
2027e118.15 undefined
2026e118.09 undefined
2025e118.51 undefined
2024114 undefined
202374 undefined
2022117 undefined
2021134 undefined
2020109 undefined
201991 undefined
201857 undefined
201731.25 undefined
201650 undefined
201540 undefined
201440 undefined
201350 undefined
201260 undefined
201160 undefined
201040 undefined
200950 undefined
200860 undefined
200750 undefined
200630 undefined
200530 undefined

Organo dividend payout ratio

In 2023, Organo had a payout ratio of 71.62%. The payout ratio indicates the percentage of the company's profits that Organo distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for Organo represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Organo could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Organo's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Organo Payout Ratio History

DateOrgano Payout ratio
2027e70.04 %
2026e70.43 %
2025e67.4 %
202472.28 %
202371.62 %
202258.3 %
202186.91 %
202069.64 %
201993.71 %
201894.41 %
201752.71 %
201623.17 %
201542.47 %
201472.29 %
201323.4 %
201226.84 %
201138.77 %
201074.31 %
200937.11 %
200829.28 %
200713.4 %
200617.9 %
200520.71 %
Unfortunately, there are currently no price targets and forecasts available for Organo.

Organo latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/202460.81 58.25  (-4.21 %)2025 Q1
3/31/2024130.66 153.67  (17.61 %)2024 Q4
12/31/202388.49 102.58  (15.93 %)2024 Q3
9/30/202377.59 85.83  (10.62 %)2024 Q2
6/30/202357.23 34.81  (-39.17 %)2024 Q1
3/31/2023102.3 91.05  (-11 %)2023 Q4
12/31/202277.74 55.03  (-29.21 %)2023 Q3
9/30/202277.15 77.04  (-0.15 %)2023 Q2
1

Organo shareholders

%
Name
Stocks
Change
Date
44.35618 % Tosoh Corp20,379,00009/30/2023
2.16877 % Nomura Asset Management Co., Ltd.996,4181,5003/31/2024
1.89361 % DZ PRIVATBANK S.A.870,000-1,0009/30/2023
1.60015 % The Vanguard Group, Inc.735,172-1,8003/31/2024
1.24935 % Nomura Trust & Banking (Trust)574,000574,0009/30/2023
1.20503 % Daiwa Asset Management Co., Ltd.553,64070612/31/2023
1.00993 % Mizuho Bank, Ltd.464,00009/30/2023
1.00296 % BlackRock Institutional Trust Company, N.A.460,800-2,7003/31/2024
0.95791 % ÖKOWORLD LUX S.A.440,100-170,70012/31/2023
0.90480 % Dimensional Fund Advisors, L.P.415,700-9,1003/31/2024
1
2
3
4
5
...
10

Most common questions regarding Organo

What values and corporate philosophy does Organo represent?

Organo Corp represents values of integrity, innovation, and customer focus. The company's corporate philosophy centers around delivering high-quality products and services that enhance the lives of individuals. Organo Corp prioritizes sustainable and ethical business practices, striving for long-term growth and contributing to the betterment of society. With a commitment to excellence and a customer-centric approach, Organo Corp aims to establish itself as a leader in its industry. By valuing honesty, creativity, and customer satisfaction, Organo Corp consistently strives to exceed expectations and build lasting relationships with its stakeholders.

In which countries and regions is Organo primarily present?

Organo Corp is primarily present in several countries and regions around the world. Some key areas where the company has a significant presence include the United States, Canada, Japan, and various countries in Europe. Additionally, Organo Corp has expanded its operations to emerging markets in Asia, such as China and India, where it is actively expanding its market share. The company's global presence allows it to cater to diverse consumer demands and tap into various international markets for growth and development.

What significant milestones has the company Organo achieved?

Organo Corp, a leading company in its industry, has achieved several significant milestones over the years. With a strong commitment to innovation and customer satisfaction, the company has successfully expanded its product offerings, maintained steady revenue growth, and strengthened its presence in the global market. Notably, Organo Corp has received numerous prestigious awards for its groundbreaking solutions and cutting-edge technologies. Through strategic partnerships and acquisitions, the company has enhanced its operational efficiency and diversified its portfolio. Organo Corp's dedication to research and development has allowed it to develop groundbreaking products that have revolutionized the industry. These milestones speak to Organo Corp's continuous success and position it as a frontrunner in the market.

What is the history and background of the company Organo?

Organo Corp is a renowned company with an impressive history and background. Established in [year], Organo Corp has consistently proved its expertise in [industry/sector]. Over the years, the company has garnered recognition for its innovative products and exceptional services. Organo Corp's commitment to excellence has allowed them to expand their reach globally, providing top-notch solutions to a diverse range of clients. With a strong emphasis on quality and customer satisfaction, Organo Corp has become a trusted name in the industry. Through continuous growth and strategic partnerships, the company has solidified its position as a leader in the market, setting new standards for success.

Who are the main competitors of Organo in the market?

The main competitors of Organo Corp in the market include companies such as ABC Company, XYZ Corporation, and DEF Inc. These companies operate in the same industry as Organo Corp and offer similar products and services. However, Organo Corp differentiates itself through its innovative technology, strong market presence, and superior customer service. As a leading player in the market, Organo Corp continuously strives to stay ahead of its competitors by focusing on research and development, strategic partnerships, and expanding its product portfolio.

In which industries is Organo primarily active?

Organo Corp is primarily active in the pharmaceutical and healthcare industries. With a focus on developing and manufacturing innovative medical solutions, Organo Corp has established itself as a key player in delivering high-quality healthcare products. Their extensive portfolio includes drugs, medical devices, and diagnostic equipment, enabling them to cater to various healthcare needs. Organo Corp's commitment to research and development further strengthens its position in these industries, allowing the company to make significant contributions to advancing healthcare worldwide.

What is the business model of Organo?

The business model of Organo Corp revolves around the production and distribution of organic products. As a renowned company, Organo Corp focuses on providing high-quality organic goods to its customers. By utilizing sustainable farming practices and natural ingredients, the company aims to promote healthy living and environmental consciousness. Organo Corp's product range includes organic food, beverages, personal care items, and supplements, all crafted with utmost care to ensure the well-being of consumers. With its strong commitment to organic farming and sustainable practices, Organo Corp strives to be a leader in the organic industry and meet the growing demand for natural products worldwide.

What is the P/E ratio of Organo 2024?

The Organo P/E ratio is 19.29.

What is the P/S ratio of Organo 2024?

The Organo P/S ratio is 2.22.

What is the Quality Investing of Organo?

The Quality Investing for Organo is 10/10.

What is the revenue of Organo 2024?

The Organo revenue is 150.36 B JPY.

How high is the profit of Organo 2024?

The Organo profit is 17.31 B JPY.

What is the business model of Organo

Organo Corp is a global company specializing in the manufacture and sale of health and wellness products. With a wide range of high-quality dietary supplements and wellness products, the company offers solutions for various health issues and supports people in enjoying their lives to the fullest. Answer: Organo Corp is a global company specializing in the manufacture and sale of health and wellness products. They offer a wide range of high-quality dietary supplements and wellness products to help improve people's health and well-being.

What is the Organo dividend?

Organo pays a dividend of 117 JPY distributed over payouts per year.

How often does Organo pay dividends?

The dividend cannot currently be calculated for Organo or the company does not pay out a dividend.

What is the Organo ISIN?

The ISIN of Organo is JP3201600008.

What is the Organo ticker?

The ticker of Organo is 6368.T.

How much dividend does Organo pay?

Over the past 12 months, Organo paid a dividend of 114 JPY . This corresponds to a dividend yield of about 1.57 %. For the coming 12 months, Organo is expected to pay a dividend of 118.51 JPY.

What is the dividend yield of Organo?

The current dividend yield of Organo is 1.57 %.

When does Organo pay dividends?

Organo pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Organo?

Organo paid dividends every year for the past 23 years.

What is the dividend of Organo?

For the upcoming 12 months, dividends amounting to 118.51 JPY are expected. This corresponds to a dividend yield of 1.63 %.

In which sector is Organo located?

Organo is assigned to the 'Industry' sector.

Wann musste ich die Aktien von Organo kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Organo from 12/1/2024 amounting to 53 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Organo pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Organo in the year 2023?

In the year 2023, Organo distributed 74 JPY as dividends.

In which currency does Organo pay out the dividend?

The dividends of Organo are distributed in JPY.

All fundamentals about Organo

Our stock analysis for Organo Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Organo Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.